Thomas R. Kosten

32.3k total citations · 4 hit papers
567 papers, 22.9k citations indexed

About

Thomas R. Kosten is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Pharmacology. According to data from OpenAlex, Thomas R. Kosten has authored 567 papers receiving a total of 22.9k indexed citations (citations by other indexed papers that have themselves been cited), including 203 papers in Cellular and Molecular Neuroscience, 158 papers in Epidemiology and 130 papers in Pharmacology. Recurrent topics in Thomas R. Kosten's work include Neurotransmitter Receptor Influence on Behavior (167 papers), Substance Abuse Treatment and Outcomes (121 papers) and Opioid Use Disorder Treatment (107 papers). Thomas R. Kosten is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (167 papers), Substance Abuse Treatment and Outcomes (121 papers) and Opioid Use Disorder Treatment (107 papers). Thomas R. Kosten collaborates with scholars based in United States, China and Canada. Thomas R. Kosten's co-authors include Herbert D. Kleber, Bruce J. Rounsaville, Therese A. Kosten, Earl L. Giller, Leslie K. Jacobsen, Mehmet Sofuoglu, Steven M. Southwick, Douglas Ziedonis, Xiang Yang Zhang and John Mason and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas R. Kosten

559 papers receiving 21.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the Literature

2001 775 citations Thomas R. Kosten et al. profile →
Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction

2007 579 citations Patrick G. O’Connor, Thomas R. Kosten et al. Annals of Internal Medicine profile →
Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID‐19 Pandemic in China

2020 361 citations Yanping Bao, Thomas R. Kosten et al. American Journal on Addictions profile →
Internet Addiction Increases in the General Population During COVID‐19: Evidence From China

2021 144 citations Yanping Bao, Thomas R. Kosten et al. American Journal on Addictions profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas R. Kosten United States	77	7.3k	5.1k	4.3k	3.9k	3.9k	567	22.9k
Henry R. Kranzler United States	88	8.2k 1.1×	10.8k 2.1×	5.1k 1.2×	3.3k 0.9×	3.2k 0.8×	610	28.2k
Joel Gelernter United States	91	7.9k 1.1×	4.1k 0.8×	5.9k 1.4×	3.7k 0.9×	2.3k 0.6×	589	26.7k
Charles P. O’Brien United States	77	9.3k 1.3×	7.8k 1.5×	3.9k 0.9×	3.1k 0.8×	3.3k 0.8×	353	24.5k
Kathleen T. Brady United States	84	4.2k 0.6×	5.2k 1.0×	9.6k 2.2×	3.8k 1.0×	2.7k 0.7×	478	23.7k
Rajita Sinha United States	90	7.1k 1.0×	4.0k 0.8×	7.5k 1.7×	2.1k 0.5×	1.7k 0.5×	349	26.5k
Marc A. Schuckit United States	85	7.7k 1.1×	11.7k 2.3×	6.1k 1.4×	3.1k 0.8×	2.4k 0.6×	500	28.7k
Harriet de Wit United States	82	12.9k 1.8×	3.5k 0.7×	5.9k 1.4×	2.8k 0.7×	4.4k 1.1×	427	28.4k
John I. Nürnberger United States	69	4.1k 0.6×	3.5k 0.7×	3.7k 0.9×	4.8k 1.2×	1.4k 0.4×	388	19.4k
Wim van den Brink Netherlands	85	5.6k 0.8×	5.4k 1.1×	9.2k 2.2×	5.1k 1.3×	4.8k 1.2×	586	25.9k
Kathleen K. Bucholz United States	81	3.5k 0.5×	9.8k 1.9×	9.3k 2.2×	3.1k 0.8×	3.2k 0.8×	461	26.3k

Countries citing papers authored by Thomas R. Kosten

Since Specialization

Citations

This map shows the geographic impact of Thomas R. Kosten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Kosten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Kosten more than expected).

Fields of papers citing papers by Thomas R. Kosten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Kosten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Kosten. The network helps show where Thomas R. Kosten may publish in the future.

Co-authorship network of co-authors of Thomas R. Kosten

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Kosten. A scholar is included among the top collaborators of Thomas R. Kosten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Kosten. Thomas R. Kosten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fava, Maurizio, Luca Pani, Sara De Martin, et al.. (2025). Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 86(1). 3 indexed citations

Lu, Tangsheng, Fanglin Liu, Shihao Huang, et al.. (2024). Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Research. 335. 115886–115886. 38 indexed citations

Swann, Alan C., David P. Graham, Anna V. Wilkinson, & Thomas R. Kosten. (2022). Suicide Risk in a National VA Sample. The Journal of Clinical Psychiatry. 83(3). 5 indexed citations

Green, Charles E., Thomas R. Kosten, Constanza de Dios, et al.. (2021). Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial. Nicotine & Tobacco Research. 23(10). 1682–1690. 62 indexed citations

Kosten, Thomas R., et al.. (2021). Current status of vaccines for substance use disorders: A brief review of human studies. Journal of the Neurological Sciences. 434. 120098–120098. 20 indexed citations

Mathai, David S., Matthew J. Meyer, Eric A. Storch, & Thomas R. Kosten. (2019). The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review. Journal of Affective Disorders. 264. 123–129. 63 indexed citations

Ma, Liangsuo, Joel L. Steinberg, Kathryn A. Cunningham, et al.. (2014). Inhibitory Behavioral Control: A Stochastic Dynamic Causal Modeling Study Using Network Discovery Analysis. Brain Connectivity. 5(3). 177–186. 16 indexed citations

Shorter, Daryl, et al.. (2013). Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and α1A-adrenoceptor gene variation. European Neuropsychopharmacology. 23(11). 1401–1407. 22 indexed citations

Zhang, Xiangyang, Da Chun Chen, Mei Hong Xiu, et al.. (2012). Plasma total antioxidant status and cognitive impairments in schizophrenia. Schizophrenia Research. 139(1-3). 66–72. 63 indexed citations

10.

Zhang, Ruiling, Wei Hao, Chuansheng Wang, et al.. (2011). The prevalence and clinical‐demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine. Human Psychopharmacology Clinical and Experimental. 26(6). 392–396. 17 indexed citations

11.

Sun, Shilong, Fan Wang, Jun Wei, et al.. (2008). Association between interleukin-3 receptor alpha polymorphism and schizophrenia in the Chinese population. Neuroscience Letters. 440(1). 35–37. 20 indexed citations

12.

Lane, Scott D., et al.. (2007). Performance of Cocaine Dependent Individuals and Controls on a Response Inhibition Task with Varying Levels of Difficulty. The American Journal of Drug and Alcohol Abuse. 33(5). 717–726. 68 indexed citations

13.

Sofuoglu, Mehmet, et al.. (2005). Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology. 181(3). 504–510. 34 indexed citations

14.

Kosten, Thomas R. & S. Michael Owens. (2005). Immunotherapy for the treatment of drug abuse. Pharmacology & Therapeutics. 108(1). 76–85. 104 indexed citations

15.

González, Gerardo, Kevin A. Sevarino, Mehmet Sofuoglu, et al.. (2003). Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study. Addiction. 98(11). 1625–1632. 96 indexed citations

16.

O’Connor, Patrick G., Kathleen M. Carroll, Julia Shi, et al.. (1997). Three Methods of Opioid Detoxification in a Primary Care Setting. Annals of Internal Medicine. 38 indexed citations

17.

Kosten, Thomas R., Frank H. Gawin, Therese A. Kosten, et al.. (1992). Six‐Month Follow‐Up of Short‐Term Pharmacotherapy for Cocaine Dependence. American Journal on Addictions. 1(1). 40–49. 32 indexed citations

18.

Kosten, Thomas R., Thomas R. Kosten, David G. Silverman, et al.. (1992). Intravenous cocaine challenges during naltrexone maintenance: A preliminary study. Biological Psychiatry. 32(6). 543–548. 36 indexed citations

19.

Schottenfeld, Richard S., et al.. (1992). Treatment of dual diagnosis patients: A relapse prevention group approach. Journal of Substance Abuse Treatment. 9(4). 305–309. 22 indexed citations

20.

Kosten, Thomas R., Thomas R. Kosten, Therese A. Kosten, Therese A. Kosten, & Bruce J. Rounsaville. (1991). Alcoholism and depressive disorders in opioid addicts and their family members. Comprehensive Psychiatry. 32(6). 521–527. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact